問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
李婉若
下載
2025-02-01 - 2025-08-05
Condition/Disease
The study aimed to evaluate the efficacy of SAR444656 compared to placebo in treating AD lesions in adult subjects with moderate to severe AD. • Percentage change in EASI from baseline to week 16.
Test Drug
SAR444656
Participate Sites4Sites
Recruiting4Sites
2023-04-01 - 2031-12-31
Participate Sites7Sites
Recruiting7Sites
2025-03-01 - 2027-12-31
Participate Sites3Sites
Recruiting3Sites
2024-09-15 - 2026-12-31
2026-05-01 - 2027-12-31
Participate Sites8Sites
Recruiting8Sites
2021-09-01 - 2026-12-31
Participate Sites5Sites
Recruiting5Sites
2026-04-01 - 2027-03-31
Participate Sites1Sites
Recruiting1Sites
2025-10-01 - 2028-04-30
2020-01-09 - 2026-02-28
Participate Sites6Sites
Recruiting6Sites
2024-01-01 - 2027-12-31
全部
